
While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …

As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …

In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …

It’s Friday, and it’s been a week characterised by a range of promising research results, particularly into HIV and Duchenne …

It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

Two of our top five stories this month are about one company in particular – a company that’s having a …

We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …

The start of 2017 has already had some big stories hit the news, with many companies taking the opportunity to …

As we’re now in the New Year, here at Pharmafocus, we thought we would do a recap of the ten …

Christmas is nearly here, but there isn’t much Christmas cheer to be had in the pharmaceutical industry. It’s been a …

This week has been an interesting one for pharmaceutical innovation. A number of stories and studies have arisen about trialling …

This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …

This week has seen pharmaceutical companies release their third quarter profits, good news for some whilst others have attempted to …

This week has seen a lot of news regarding specific drugs going through trial and some impressive results within. Read …